By G HossainPosted on April 13, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Replimune’s CEO Sushil Patel has already warned that the biotech will need to cut staff and substantially scale back its U.S. manufacturing operations. Second rejection for tumor destroyer puts Replimune on a ‘challenging path’ Post navigation Seaport, Hemab set sail for NasdaqRegeneron enters radiopharma ring with up to $4.3B Telix alliance